Urethral Stricture Management and Surgical Techniques

Urethral stricture disease, characterised by narrowing of the urethral lumen, arises chiefly from trauma, infection or idiopathic scarring within the corpus spongiosum. Initial assessment combines uroflowmetry, imaging and endoscopic evaluation to delineate stricture location, length and severity. Minimally invasive approaches such as dilation and internal urethrotomy offer short-term relief but carry high recurrence rates. Definitive management is generally achieved by urethroplasty, with excision and primary anastomosis favoured for short bulbar strictures and graft-onlay techniques, most commonly using buccal mucosa, reserved for longer or complex defects. Advances in operative planning, including three-dimensional imaging and intraoperative endoscopic guidance, have optimised tissue preservation and reduced morbidity. Emerging strategies focus on modulating wound healing through localised drug delivery, anti-fibrotic coatings and tissue-engineered substitutes to diminish scar formation and enhance graft integration. Globally, these innovations hold promise for improving patient quality of life, reducing healthcare burden and standardising reconstructive outcomes across diverse clinical settings.

Research from Nature Portfolio

Recent studies have explored nanofilm-based coatings on indwelling catheters to deliver anti-fibrotic agents continuously, demonstrating reduced fibroblast-derived collagen deposition and enhanced enzymatic collagen degradation in animal models, thereby preserving urethral calibre after injury. In parallel, in vivo investigations of urinary extravasation following urethral trauma have delineated the sequence of epithelial proliferation, mesenchymal oedema and spongio-fibrosis, offering novel insights into post-surgical tissue remodelling and identifying potential molecular targets for therapeutic intervention.

Urethral Stricture Management and Surgical Techniques publication trend

The graph below shows the total number of articles in urethral stricture management and surgical techniques across all publications each year (not limited to Nature Index journals).

Technical terms

Extracellular matrix: network of proteins and polysaccharides providing structural support to urethral tissue and influencing fibrotic processes.

Spongio-fibrosis: fibrous scarring within the corpus spongiosum leading to urethral lumen narrowing.

Anastomotic urethroplasty: surgical excision of a stricture segment followed by direct reconnection of healthy urethral ends.

Buccal mucosal graft: graft harvested from the inner cheek used to reconstruct or augment the urethra.

Nanofilm-controlled drug delivery: thin protein or polymer coating on a catheter enabling sustained local release of anti-fibrotic agents.

References

1. Rectifying disorder of extracellular matrix to suppress urethral stricture by protein nanofilm-controlled drug delivery from urinary catheter. Nature Communications (2023).
2. Inhibition of urethral stricture by a catheter loaded with nanoparticle/ pirfenidone complexes. Frontiers in Bioengineering and Biotechnology (2023).
3. Wound healing responses of urinary extravasation after urethral injury. Scientific Reports (2023).
4. Endoscopic treatments prior to urethroplasty: trends in management of urethral stricture disease. BMC Urology (2020).
5. Recent Advances in treatment of urethral stricture disease in men. F1000Research (2020).
6. A Comprehensive Review Emphasizing Anatomy, Etiology, Diagnosis, and Treatment of Male Urethral Stricture Disease. BioMed Research International (2019).